Mairs & Power Inc. raised its position in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,079,483 shares of the biotechnology company’s stock after buying an additional 25,903 shares during the quarter. […]
Mairs & Power Inc. raised its position in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,079,483 shares of the biotechnology company’s stock after buying an additional 25,903 shares during the quarter. […]
Rhenman & Partners Asset Management AB decreased its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 62.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,000 shares of the biotechnology company’s stock after selling 26,680 shares during the period. Rhenman & Partners […]
Isthmus Partners LLC purchased a new stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 3,845 shares of the biotechnology company’s stock, valued at approximately $297,000. Several other hedge funds and other institutional investors have also modified their holdings of […]
MINNEAPOLIS, May 31, 2024 /PRNewswire/ Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor.